Literature DB >> 33392808

Oral microorganisms and bloodstream infection in allogeneic hematopoietic stem cell transplantation.

Yumiko Ohbayashi1, Osamu Imataki2, Makiko Uemura2, Akihiro Takeuchi3, Saki Aoki4, Mao Tanaka4, Yasuhiro Nakai4, Fumi Nakai4, Minoru Miyake4.   

Abstract

OBJECTIVES: We aimed to compare oral and pathogenic microorganisms in bloodstream infections (BSIs) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). We also investigated the relationship between BSIs and oral mucositis to identify the ratio of BSIs caused by oral microorganisms and the pathogenic microorganisms involved.
MATERIALS AND METHODS: We collected data on BSIs in 96 patients who underwent allo-HSCT in our institute between April 2009 and December 2019, including BSI pathogens isolated from blood cultures (BBSIs) and microorganisms isolated from washing the oral cavity with sterile distilled water. Oral microorganisms obtained at the onset of BSI (OBSIs) and during allo-HSCT (OSCTs) were defined as isolates collected during the week of blood culturing. Study entry was limited to samples collected up to 1 month after allo-HSCT without BSI. When the BBSI and OBSI were the same, we considered the oral microorganism to have caused the BSI.
RESULTS: The incidence rate of BSIs was 27%, and the predominant microorganism was coagulase-negative Staphylococci. Normal bacterial flora were decreased to 15.8% in OBSIs and 25.5% in OSCTs. The distribution of microorganisms without normal bacterial flora showed significant difference between BBSIs and OSCTs (p < 0.05). Oral mucositis was found in 72.9%, and BSI caused by oral microorganisms occurred in 46.2% of BSIs in allo-HSCT patients.
CONCLUSION: The distribution of microorganisms obtained from blood in patients with BSI during allo-HSCT was found to be similar to that of microorganisms from oral cultures. CLINICAL RELEVANCE: Oral microorganism monitoring may be able to predict BSI during allo-HSCT.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; Bloodstream infection; Oral microorganism

Mesh:

Year:  2021        PMID: 33392808     DOI: 10.1007/s00784-020-03749-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  30 in total

1.  Influence of Oral Anaerobic Bacteria on Hematopoietic Stem Cell Transplantation Patients: Oral Mucositis and General Condition.

Authors:  L Osakabe; A Utsumi; B Saito; Y Okamatsu; H Kinouchi; T Nakamaki; S Hironaka
Journal:  Transplant Proc       Date:  2017-11       Impact factor: 1.066

Review 2.  Pharmacotherapy for the management of cancer regimen-related oral mucositis.

Authors:  Alessandro Villa; Stephen T Sonis
Journal:  Expert Opin Pharmacother       Date:  2016-08-03       Impact factor: 3.889

3.  Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.

Authors:  Chen-Hua Yan; Yu Wang; Xiao-Dong Mo; Yu-Qian Sun; Feng-Rong Wang; Hai-Xia Fu; Yao Chen; Ting-Ting Han; Jun Kong; Yi-Fei Cheng; Xiao-Hui Zhang; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

4.  Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.

Authors:  B A Collin; H L Leather; J R Wingard; R Ramphal
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark.

Authors:  Rasmus Sørrig; Tobias W Klausen; Morten Salomo; Annette Vangsted; Peter Gimsing
Journal:  Eur J Haematol       Date:  2018-05-04       Impact factor: 2.997

6.  Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.

Authors:  Malgorzata Mikulska; Anna Maria Raiola; Federica Galaverna; Elisa Balletto; Maria Lucia Borghesi; Riccardo Varaldo; Francesca Gualandi; Livia Giannoni; Giordana Pastori; Daniele Roberto Giacobbe; Alessio Signori; Valerio Del Bono; Claudio Viscoli; Andrea Bacigalupo; Emanuele Angelucci
Journal:  Biol Blood Marrow Transplant       Date:  2017-08-30       Impact factor: 5.742

7.  Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.

Authors:  Judith E Raber-Durlacher; Alexa M G A Laheij; Joel B Epstein; Matthew Epstein; Gerard M Geerligs; Gordon N Wolffe; Nicole M A Blijlevens; J Peter Donnelly
Journal:  Support Care Cancer       Date:  2013-01-04       Impact factor: 3.603

Review 8.  Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.

Authors:  E Montassier; E Batard; T Gastinne; G Potel; M F de La Cochetière
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

9.  Bloodstream infections in cancer patients. Risk factors associated with mortality.

Authors:  Beda Islas-Muñoz; Patricia Volkow-Fernández; Cynthia Ibanes-Gutiérrez; Alberto Villamar-Ramírez; Diana Vilar-Compte; Patricia Cornejo-Juárez
Journal:  Int J Infect Dis       Date:  2018-04-09       Impact factor: 3.623

10.  The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.

Authors:  Jing Ge; Tingting Yang; Lei Zhang; Xuhan Zhang; Xiaoyu Zhu; Baolin Tang; Xiang Wan; Juan Tong; Kaidi Song; Wen Yao; Guangyu Sun; Zimin Sun; Huilan Liu
Journal:  BMC Infect Dis       Date:  2018-12-13       Impact factor: 3.090

View more
  1 in total

Review 1.  The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation.

Authors:  Tirthankar Sen; Rajkumar P Thummer
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.